Onderneming Cognition Therapeutics, Inc.
Aandelen
CGTX
US19243B1026
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,985 USD | -0,75% | +4,74% | +7,57% |
12/04 | Transcript : Cognition Therapeutics, Inc. - Special Call | |
26/03 | Transcript : Cognition Therapeutics, Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Vakgebied
Aantal werknemers: 27
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 01-03-19 |
John Doyle
DFI | Director of Finance/CFO | 46 | 01-05-23 |
Paul J. Tiseo
CTO | Chief Tech/Sci/R&D Officer | - | 11-10-22 |
Mary Hamby
CTO | Chief Tech/Sci/R&D Officer | - | - |
Anthony Caggiano
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-04-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Lisa Ricciardi
CEO | Chief Executive Officer | 64 | 01-03-19 |
Brett Monia
BRD | Director/Board Member | 62 | 01-10-20 |
Ellen Richstone
BRD | Director/Board Member | 72 | 01-11-21 |
Jack Khattar
CHM | Chairman | 62 | 01-01-20 |
Peggy Wallace
BRD | Director/Board Member | 67 | 01-09-16 |
Aaron Fletcher
BRD | Director/Board Member | 44 | 01-01-15 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 39 000 152 | 35 015 125 ( 89,78 %) | 0 | 89,78 % |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,57% | 78 mln. | |
-1,45% | 105 mld. | |
+3,50% | 97,5 mld. | |
+1,86% | 22,19 mld. | |
-16,61% | 21,33 mld. | |
-8,49% | 18,68 mld. | |
-42,33% | 16,6 mld. | |
-20,57% | 14,52 mld. | |
+5,43% | 14,09 mld. | |
+28,82% | 10,99 mld. |
- Beurs
- Aandelen
- Koers CGTX
- Onderneming Cognition Therapeutics, Inc.